Illumina MiSeq i100 System

About this opportunity

This requirement is for the acquisition of one (1) Illumina MiSeq i100 Whole Genome Sequencing System for the FDA Irvine Medical Products Laboratory (IRVLMP). The procurement is being conducted on a sole-source basis under RFO FAR Part 12 and FAR 13.106-1(b)(1), as the Illumina MiSeq i100 System is the only system determined capable of meeting the Government�s minimum requirements for compatibility with existing validated laboratory workflows, consumables, sequencing methods, software environments, and operational procedures. The requirement includes associated components, software, delivery, installation, training, and manufacturer warranty support.